SEM stock holds near 52-week high as investors weigh Select Medical’s latest margins

SEM stock from Select Medical is trading close to its 52-week high while investors digest the company’s most recent profitability metrics and dividend yield in the healthcare providers and services sector.

Select Medical Holdings stock (ISIN US81642T1007, ticker SEM) is trading close to its 52-week high, underscoring solid investor interest in the specialized healthcare provider as of September 3, 2026. According to market data compiled by MarketBeat, SEM shares recently traded in a daily range around 16.51 US dollars, within a 52-week span of 11.65 to 16.99 US dollars.

Valuation, yield and recent trading range

The same MarketBeat overview, updated on September 4, 2026, shows that Select Medical carries a market capitalization of about 2.05 billion US dollars at its current share price, reflecting a mid-cap valuation in the US healthcare providers and services space. SEM stock is valued at a price-to-earnings ratio of 15.58, positioning the company at a moderate earnings multiple compared with many higher-growth healthcare peers.

For income-oriented investors, Select Medical offers a dividend yield of 1.51 percent based on the latest figures reported by MarketBeat. While not a high-yield stock, this payout adds a small income component on top of potential capital appreciation. Importantly for technical observers, the current share price sitting close to the 52-week high of 16.99 US dollars suggests that the market has steadily re-rated SEM from the 52-week low of 11.65 US dollars, a gain of roughly 45 percent from the low to the high over the period.

Business profile and recent fundamentals context

Select Medical is described in the MarketBeat profile as a leading provider of specialized healthcare services in the United States, operating through two main segments: the Hospital Division and the Outpatient Rehabilitation Division. These segments focus on long-term acute care and inpatient rehabilitation on one side and physical therapy and related outpatient services on the other side, giving the company exposure to both facility-based care and more flexible outpatient treatment.

While the day-filtered sources available on September 4, 2026, do not enumerate fresh quarterly revenue or earnings details for Select Medical within 2026, the valuation and market-capitalization metrics themselves provide clues about the profitability backdrop. A P/E ratio of 15.58 in combination with a 2.05 billion US-dollar market cap implies annual net earnings in the low hundreds of millions of US dollars, based on the simple relationship that market capitalization divided by the P/E multiple approximates trailing net income. Against this earnings base, the 1.51 percent dividend yield suggests that the company is retaining a substantial portion of profits to invest in operations and debt management rather than distributing a high share to shareholders.

From an operational perspective, the split between hospital-based services and outpatient rehabilitation means that Select Medical’s performance is sensitive to trends in post-acute care demand, referral patterns from larger health systems and insurers’ reimbursement policies. Investors typically monitor margins in both segments, as inpatient facilities tend to be more capital-intensive while outpatient rehabilitation can scale with lower fixed costs, influencing the overall profitability mix.

Hospital and outpatient rehabilitation services

Select Medical’s Hospital Division typically includes long-term acute care hospitals and inpatient rehabilitation facilities that cater to patients with complex medical conditions requiring extended stays and intensive rehabilitation. These facilities often receive referrals from larger general hospitals after the acute phase of treatment, positioning Select Medical as a key partner in the continuum of care for conditions such as stroke, severe trauma and complex surgeries.

The Outpatient Rehabilitation Division encompasses physical therapy and related rehabilitation services delivered through clinics and centers across multiple states. Here, volumes are driven by orthopedic recovery, sports injuries, chronic musculoskeletal conditions and post-surgical rehabilitation. Because outpatient centers can adjust staffing and hours more flexibly than hospitals, this segment can be an important driver of margin resilience, especially when demand responds to demographic aging and greater awareness of physical therapy as a tool to avoid more invasive procedures.

Stock perspective and price level

With SEM stock trading near the top of its 52-week range and underpinned by a market capitalization of about 2.05 billion US dollars as of September 3, 2026, investors are signaling confidence in Select Medical’s ability to generate steady earnings within the US healthcare providers and services industry. The combination of a P/E ratio of 15.58 and a dividend yield of 1.51 percent suggests a balanced profile of moderate growth expectations and modest income, rather than a high-growth or deep-value narrative.

In this environment, the current SEM share price around 16.51 US dollars as reported by MarketBeat, compared with the 52-week high of 16.99 US dollars and the low of 11.65 US dollars, gives investors a clear reference point for evaluating further upside or downside. For now, SEM stock remains supported by its specialized position in post-acute and rehabilitation care, and by a valuation that leaves room for performance-driven rerating if margins and revenues expand in coming reporting periods.

Key data on SEM stock

• Company: Select Medical Holdings Corporation
• ISIN: US81642T1007
• Ticker: SEM
• Trading venue: NYSE
• Price (as of September 3, 2026): 16.51 USD
• Market capitalization: 2.05 billion USD (as of September 3, 2026)
• Sector / Industry: Healthcare Providers and Services
• Index membership: US mid-cap universe, healthcare sector